PeptideDB

Aurantio-obtusin

CAS No.: 67979-25-3

1. Biotransformation of glucoAurantio-obtusin towards Aurantio-obtusin increased the toxicity of irinotecan through incr
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description 1. Biotransformation of glucoAurantio-obtusin towards Aurantio-obtusin increased the toxicity of irinotecan through increased inhibition of SN-38 glucuronidation. 2. Aurantio-obtusin, stimulated chemotactic migration of MC3T3-E1 osteoblast cells in a concentration-dependent manner. Besides migration, the compound stimulated osteoblast differentiation and mineralization. 3. Aurantio-obtusin is a promising osteoanabolic compound of natural origin with potential therapeutic applications in the prevention of osteoporosis and other metabolic bone diseases.
molecular weight 330.29
Molecular formula C17H14O7
CAS 67979-25-3
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility DMSO: 60 mg/mL (181.7 mM) Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.: Soluble
References 1. Vishnuprasad C N , Tsuchiya T , Kanegasaki S , et al. Aurantio-obtusin stimulates chemotactic migration and differentiation of MC3T3-E1 osteoblast cells.[J]. Planta Medica, 2014, 80(07):544-549.